静脉铁剂给药导致[99mTc]Tc-DPD闪烁显像诊断心脏淀粉样变性的假阳性
一例86岁女性射血分数保留的心力衰竭患者,因疑似转甲状腺素蛋白心脏淀粉样变性行[99mTc]Tc-DPD闪烁显像及SPECT/CT,首次扫描显示心脏和肝脏摄取;因患者当日早晨接受过静脉铁剂,重复扫描显示心脏和肝脏均无摄取,据此判断首次结果为药物相互作用所致的假阳性。
要点
- 静脉铁剂给药可能导致[99mTc]Tc-DPD闪烁显像出现心脏和肝脏假阳性摄取。
- 对疑似转甲状腺素蛋白心脏淀粉样变性患者,若近期接受静脉铁剂,扫描结果需谨慎判读。
- 重复扫描有助于排除可逆性药物干扰所致的假阳性。
核心结论
- 静脉铁剂给药可导致[99mTc]Tc-DPD闪烁显像出现心脏和肝脏假阳性摄取,重复扫描可排除该干扰。
研究设计与样本
- 病例报告:一例86岁女性射血分数保留的心力衰竭患者,因疑似转甲状腺素蛋白心脏淀粉样变性行[99mTc]Tc-DPD闪烁显像及SPECT/CT。
主要发现
- 首次[99mTc]Tc-DPD扫描显示心脏和肝脏摄取;因患者当日早晨接受过静脉铁剂,重复扫描显示心脏和肝脏均无摄取。
- 据此判断首次结果为药物相互作用所致的假阳性。
临床怎么用
- 对疑似转甲状腺素蛋白心脏淀粉样变性患者行[99mTc]Tc-DPD闪烁显像时,需注意近期静脉铁剂给药可能造成心脏和肝脏假阳性摄取。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
[ 99m Tc]Tc-DPD (3,3-diphosphono-1,2-propanodicarboxylic acid) scintigraphy is an essential tool for diagnosing transthyretin amyloid cardiac amyloidosis. An 86-year-old woman suffering from heart failure with preserved ejection fraction underwent [ 99m Tc]Tc-DPD scintigraphy and a SPECT/CT for suspected transthyretin amyloid cardiac amyloidosis. The scan showed intracardiac and liver uptake. As the patient had taken intravenous iron on the morning of the scan, we decided to repeat the scan, but this time, it showed no uptake in the heart or the liver. Accordingly, we concluded the first result was a false positive due to drug interaction.
引用
- Rudolphi Solero T, Feriche Aragón M, Amrani Raissouni T, et al. False Positive in [ 99m Tc]Tc-DPD Scintigraphy for Cardiac Amyloidosis Due to Intravenous Iron Administration. Clin Nucl Med. 2023. PMID: 38048549. doi:10.1097/RLU.0000000000004981
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。